The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov.…
LEEDS, England, Nov. 27, 2024 /PRNewswire/ -- Deepmatter, a leading innovator in digital chemistry, today unveils its rebrand to ChemAI, as part…
Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand…
BRISBANE, AUSTRALIA / ACCESSWIRE / November 26, 2024 / The healthcare landscape in Australia has taken a significant stride forward…
Renowned Facial Plastic Surgeon Dr. Rubinstein has been selected to train professionals on FDA-approved BOTOX® Cosmetic for neck rejuvenation in…
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)Primary analysis data in potentially pivotal GBM…
FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule,…
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in discovery of inhibitors of challenging targets for…
MALVERN, Pa., Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform…
Prospective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical…